Literature DB >> 27798289

Antigen Masking During Fixation and Embedding, Dissected.

Carla Rossana Scalia1, Giovanna Boi1, Maddalena Maria Bolognesi1, Lorella Riva2, Marco Manzoni1, Linde DeSmedt3, Francesca Maria Bosisio1,3, Susanna Ronchi1, Biagio Eugenio Leone1,2, Giorgio Cattoretti1,2.   

Abstract

Antigen masking in routinely processed tissue is a poorly understood process caused by multiple factors. We sought to dissect the effect on antigenicity of each step of processing by using frozen sections as proxies of the whole tissue. An equivalent extent of antigen masking occurs across variable fixation times at room temperature. Most antigens benefit from longer fixation times (>24 hr) for optimal detection after antigen retrieval (AR; for example, Ki-67, bcl-2, ER). The transfer to a graded alcohol series results in an enhanced staining effect, reproduced by treating the sections with detergents, possibly because of a better access of the polymeric immunohistochemical detection system to tissue structures. A second round of masking occurs upon entering the clearing agent, mostly at the paraffin embedding step. This may depend on the non-freezable water removal. AR fully reverses the masking due both to the fixation time and the paraffin embedding. AR itself destroys some epitopes which do not survive routine processing. Processed frozen sections are a tool to investigate fixation and processing requirements for antigens in routine specimens.

Entities:  

Keywords:  FFPE; antigen retrieval; fixation; formalin; immunostaining

Mesh:

Substances:

Year:  2016        PMID: 27798289      PMCID: PMC5256198          DOI: 10.1369/0022155416673995

Source DB:  PubMed          Journal:  J Histochem Cytochem        ISSN: 0022-1554            Impact factor:   2.479


  32 in total

1.  Daratumumab, a novel therapeutic human CD38 monoclonal antibody, induces killing of multiple myeloma and other hematological tumors.

Authors:  Michel de Weers; Yu-Tzu Tai; Michael S van der Veer; Joost M Bakker; Tom Vink; Daniëlle C H Jacobs; Lukas A Oomen; Matthias Peipp; Thomas Valerius; Jerry W Slootstra; Tuna Mutis; Wim K Bleeker; Kenneth C Anderson; Henk M Lokhorst; Jan G J van de Winkel; Paul W H I Parren
Journal:  J Immunol       Date:  2010-12-27       Impact factor: 5.422

Review 2.  Assessment of antigen damage in immunohistochemistry. The vimentin internal control.

Authors:  H Battifora
Journal:  Am J Clin Pathol       Date:  1991-11       Impact factor: 2.493

3.  Whole-slide, quadruple immunofluorescence labeling of routinely processed paraffin sections.

Authors:  Serena Buscone; Maria C Argentieri; Daniela Pilla; Giorgio Cattoretti
Journal:  Appl Immunohistochem Mol Morphol       Date:  2014-04

4.  Macromolecular changes caused by formalin fixation and antigen retrieval.

Authors:  R W Dapson
Journal:  Biotech Histochem       Date:  2007-06       Impact factor: 1.718

5.  Detection of immune deposits in glomeruli: the masking effect on antigenicity of formalin in the presence of proteins.

Authors:  J Hed; S Eneström
Journal:  J Immunol Methods       Date:  1981       Impact factor: 2.303

6.  Modeling formalin fixation and antigen retrieval with bovine pancreatic ribonuclease A: I-structural and functional alterations.

Authors:  Vladimir K Rait; Timothy J O'Leary; Jeffrey T Mason
Journal:  Lab Invest       Date:  2004-03       Impact factor: 5.662

7.  'Tissue surrogates' as a model for archival formalin-fixed paraffin-embedded tissues.

Authors:  Carol B Fowler; Robert E Cunningham; Timothy J O'Leary; Jeffrey T Mason
Journal:  Lab Invest       Date:  2007-05-28       Impact factor: 5.662

8.  Epitope recognition in the human-pig comparison model on fixed and embedded material.

Authors:  Carla Rossana Scalia; Rossella Gendusa; Maria Basciu; Lorella Riva; Lorenza Tusa; Antonella Musarò; Silvio Veronese; Angelo Formenti; Donatella D'Angelo; Angela Gabriella Ronzio; Giorgio Cattoretti; Maddalena Maria Bolognesi
Journal:  J Histochem Cytochem       Date:  2015-07-24       Impact factor: 2.479

9.  Recommendations for human epidermal growth factor receptor 2 testing in breast cancer: American Society of Clinical Oncology/College of American Pathologists clinical practice guideline update.

Authors:  Antonio C Wolff; M Elizabeth H Hammond; David G Hicks; Mitch Dowsett; Lisa M McShane; Kimberly H Allison; Donald C Allred; John M S Bartlett; Michael Bilous; Patrick Fitzgibbons; Wedad Hanna; Robert B Jenkins; Pamela B Mangu; Soonmyung Paik; Edith A Perez; Michael F Press; Patricia A Spears; Gail H Vance; Giuseppe Viale; Daniel F Hayes
Journal:  Arch Pathol Lab Med       Date:  2013-10-07       Impact factor: 5.534

10.  Microfluidic processor allows rapid HER2 immunohistochemistry of breast carcinomas and significantly reduces ambiguous (2+) read-outs.

Authors:  Ata Tuna Ciftlik; Hans-Anton Lehr; Martin A M Gijs
Journal:  Proc Natl Acad Sci U S A       Date:  2013-03-11       Impact factor: 11.205

View more
  12 in total

Review 1.  MALDI Mass Spectrometry Imaging of N-Linked Glycans in Cancer Tissues.

Authors:  R R Drake; T W Powers; E E Jones; E Bruner; A S Mehta; P M Angel
Journal:  Adv Cancer Res       Date:  2016-12-20       Impact factor: 6.242

2.  The Impact of Pre-analytical Quality Initiatives on Cholangiocarcinoma Diagnostics in Thailand.

Authors:  Supinda Koonmee; Sakkarn Sangkhamanon; Piyapharom Intarawichian; Chaiwat Aphivatanasiri; Waritta Kunprom; Prakasit Sa-Ngiamwibool; Suwit Balthaisong; Chitsakul Phuyao; Piya Prajumwongs; Reza Alaghehbandan; Malinee Thanee
Journal:  Front Public Health       Date:  2022-06-10

3.  α-Synuclein fibril-specific nanobody reduces prion-like α-synuclein spreading in mice.

Authors:  Yemima R Butler; Yuqing Liu; Ramhari Kumbhar; Peiran Zhao; Kundlik Gadhave; Ning Wang; Yanmei Li; Xiaobo Mao; Wenjing Wang
Journal:  Nat Commun       Date:  2022-07-19       Impact factor: 17.694

4.  Characterization of gut-homing molecules in non-endstage livers of patients with primary sclerosing cholangitis and inflammatory bowel disease.

Authors:  Manon de Krijger; Thijmen Visseren; Manon E Wildenberg; Gerrit K J Hooijer; Monique M A Verstegen; Luc J W van der Laan; Wouter J de Jonge; Joanne Verheij; Cyriel Y Ponsioen
Journal:  J Transl Autoimmun       Date:  2020-04-09

5.  Multiplex Staining by Sequential Immunostaining and Antibody Removal on Routine Tissue Sections.

Authors:  Maddalena Maria Bolognesi; Marco Manzoni; Carla Rossana Scalia; Stefano Zannella; Francesca Maria Bosisio; Mario Faretta; Giorgio Cattoretti
Journal:  J Histochem Cytochem       Date:  2017-07-10       Impact factor: 2.479

6.  Characterization of the human myelin oligodendrocyte glycoprotein antibody response in demyelination.

Authors:  Fiona Tea; Joseph A Lopez; Sudarshini Ramanathan; Vera Merheb; Fiona X Z Lee; Alicia Zou; Deepti Pilli; Ellis Patrick; Anneke van der Walt; Mastura Monif; Esther M Tantsis; Eppie M Yiu; Steve Vucic; Andrew P D Henderson; Anthony Fok; Clare L Fraser; Jeanette Lechner-Scott; Stephen W Reddel; Simon Broadley; Michael H Barnett; David A Brown; Jan D Lunemann; Russell C Dale; Fabienne Brilot
Journal:  Acta Neuropathol Commun       Date:  2019-09-03       Impact factor: 7.801

7.  Comparison of Different Tissue Clearing Methods for Three-Dimensional Reconstruction of Human Brain Cellular Anatomy Using Advanced Imaging Techniques.

Authors:  Marina Scardigli; Luca Pesce; Niamh Brady; Giacomo Mazzamuto; Vladislav Gavryusev; Ludovico Silvestri; Patrick R Hof; Christophe Destrieux; Irene Costantini; Francesco S Pavone
Journal:  Front Neuroanat       Date:  2021-11-11       Impact factor: 3.856

Review 8.  Fluorescence Microscopy-An Outline of Hardware, Biological Handling, and Fluorophore Considerations.

Authors:  Shane M Hickey; Ben Ung; Christie Bader; Robert Brooks; Joanna Lazniewska; Ian R D Johnson; Alexandra Sorvina; Jessica Logan; Carmela Martini; Courtney R Moore; Litsa Karageorgos; Martin J Sweetman; Douglas A Brooks
Journal:  Cells       Date:  2021-12-23       Impact factor: 6.600

9.  3D molecular phenotyping of cleared human brain tissues with light-sheet fluorescence microscopy.

Authors:  Luca Pesce; Marina Scardigli; Vladislav Gavryusev; Annunziatina Laurino; Giacomo Mazzamuto; Niamh Brady; Giuseppe Sancataldo; Ludovico Silvestri; Christophe Destrieux; Patrick R Hof; Irene Costantini; Francesco S Pavone
Journal:  Commun Biol       Date:  2022-05-12

10.  Metabolism and disposition of oseltamivir (OS) in rats, determined by immunohistochemistry with monospecific antibody for OS or its active metabolite oseltamivir carboxylate (OC): A possibility of transporters dividing the drugs' excretion into the bile and kidney.

Authors:  Kunio Fujiwara; Yutaro Yamamoto; Tetsuya Saita; Senya Matsufuji
Journal:  Pharmacol Res Perspect       Date:  2020-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.